Hyung Ryong Moon Selected Research

(2RS,4R)- 2- (2,4- dihydroxyphenyl)thiazolidine- 4- carboxylic acid

4/2012

Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyung Ryong Moon Research Topics

Disease

24	Melanoma (Melanoma, Malignant) 05/2022 - 04/2012
16	Neoplasms (Cancer) 03/2020 - 05/2003
12	Inflammation (Inflammations) 03/2022 - 01/2013
11	Hyperpigmentation 01/2021 - 04/2011
11	Insulin Resistance 01/2020 - 01/2013
8	Colonic Neoplasms (Colon Cancer) 09/2019 - 05/2002
6	Body Weight (Weight, Body) 05/2021 - 01/2013
6	Breast Neoplasms (Breast Cancer) 09/2018 - 10/2011
5	Pigmentation Disorders (Ito Syndrome) 01/2019 - 10/2013
5	Colitis 01/2018 - 01/2015
4	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 03/2014
4	Prostatic Neoplasms (Prostate Cancer) 03/2020 - 05/2011
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 08/2012
3	Stomach Neoplasms (Stomach Cancer) 12/2018 - 07/2015
3	Melanosis (Freckles) 12/2018 - 10/2013
3	Carcinoma (Carcinomatosis) 07/2015 - 08/2010
2	Fibrosis (Cirrhosis) 03/2022 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2019
2	Neuroinflammatory Diseases 11/2021 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 08/2010
2	Weight Gain 08/2018 - 01/2017
2	Non-alcoholic Fatty Liver Disease 08/2018 - 01/2018
2	Fatty Liver 01/2018 - 01/2018
2	Obesity 01/2018 - 01/2017
2	Hypoglycemia (Reactive Hypoglycemia) 08/2012 - 03/2012
1	Carcinogenesis 07/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Persistent Infection 10/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Neuroblastoma 01/2019
1	Lentigo (Lentiginosis) 12/2018

Drug/Important Bio-Agent (IBA)

29	Monophenol Monooxygenase (Tyrosinase)IBA 05/2022 - 04/2011
23	Melanins (Melanin)IBA 05/2022 - 04/2012
12	Melanocyte-Stimulating Hormones (MSH)IBA 05/2021 - 04/2012
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 01/2013
6	SirtuinsIBA 07/2022 - 01/2016
6	Histone Deacetylase InhibitorsIBA 03/2020 - 08/2010
5	Sirtuin 1IBA 07/2022 - 01/2018
5	LipidsIBA 01/2020 - 01/2018
4	kojic acidIBA 05/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Histone Deacetylases (Histone Deacetylase)IBA 03/2020 - 08/2010
4	AcidsIBA 01/2020 - 01/2013
4	Pharmaceutical PreparationsIBA 09/2019 - 06/2011
4	MHY-449IBA 11/2015 - 12/2012
4	N1- hydroxy- N8- (4- phenoxyphenyl)octanediamideIBA 08/2015 - 08/2010
3	Histones (Histone)IBA 01/2022 - 06/2013
3	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 05/2021 - 03/2018
3	Antineoplastic Agents (Antineoplastics)IBA 03/2020 - 06/2013
3	Vorinostat FDA Link 03/2020 - 08/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2003
3	Insulin (Novolin)FDA Link 01/2018 - 01/2013
3	Hydroxamic Acids (Hydroxamic Acid)IBA 08/2015 - 08/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 10/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2014
2	CaspasesIBA 01/2022 - 12/2018
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 01/2019
2	barbituric acid (barbiturate)IBA 11/2021 - 10/2017
2	MHY3200IBA 05/2021 - 08/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 03/2014
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2014
2	Microphthalmia-Associated Transcription FactorIBA 11/2018 - 04/2012
2	Hormones (Hormone)IBA 09/2018 - 01/2017
2	EnzymesIBA 01/2018 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2017
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2013
2	CytokinesIBA 01/2018 - 01/2015
2	NF-kappa B (NF-kB)IBA 10/2017 - 01/2014
2	propionic acid (potassium propionate)IBA 01/2017 - 03/2016
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2015 - 01/2015
2	MHY336IBA 03/2014 - 05/2011
2	(Z)- 5- (2,4- dihydroxybenzylidene)thiazolidine- 2,4- dioneIBA 10/2013 - 08/2013
2	Exenatide (Byetta)FDA Link 08/2012 - 03/2012
2	Palmitic Acid (Hexadecanoic Acid)IBA 08/2012 - 03/2012
1	Peptide Hydrolases (Proteases)FDA Link 03/2022
1	Adenine FDA LinkGeneric 03/2022
1	ChemokinesIBA 03/2022
1	sirtinolIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Checkpoint Kinase 1IBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 10/2021
1	Bleaching AgentsIBA 01/2021
1	Biological ProductsIBA 03/2020
1	Oleic Acid (Oleate)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Benzylidene CompoundsIBA 09/2019
1	Tumor Suppressor Protein p53IBA 09/2019
1	AmidesIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2019
1	ArbutinIBA 01/2019
1	trioctyl phosphine oxide (TOPO)IBA 12/2018
1	cyclopentanoneIBA 11/2018
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 11/2018

Therapy/Procedure

7	Therapeutics 01/2018 - 10/2012
5	Chemoprevention 11/2020 - 01/2014
2	Drug Therapy (Chemotherapy) 06/2013 - 08/2010